Gispen J G, Alarcón G S, Johnson J J, Acton R T, Barger B O, Koopman W J
J Rheumatol. 1987 Feb;14(1):74-9.
Seventy-two patients with rheumatoid arthritis had been treated with pulse weekly oral methotrexate with a mean followup of one year. Minor side effects (oral ulcers, transient elevation of liver enzymes, nausea, vomiting) were present in 46 patients (63.8%), whereas major side effects (severe infection, cytopenia, respiratory failure, seizures, gastrointestinal bleeding) were present in 7 (9.7%), 2 of whom died. Patients with major side effects had shorter disease duration and increased frequency of extraarticular manifestations as compared to those with no side effects. No association between a particular clinical or genetic variable and occurrence of side effects to methotrexate was found.
72例类风湿关节炎患者接受了每周一次的口服甲氨蝶呤冲击治疗,平均随访1年。46例患者(63.8%)出现轻微副作用(口腔溃疡、肝酶短暂升高、恶心、呕吐),而7例(9.7%)出现严重副作用(严重感染、血细胞减少、呼吸衰竭、癫痫发作、胃肠道出血),其中2例死亡。与无副作用的患者相比,出现严重副作用的患者病程较短,关节外表现的发生率更高。未发现特定临床或基因变量与甲氨蝶呤副作用发生之间存在关联。